Washington COVID-19 Biorepository
https://www.path.org/programs/diagnostics/washington-covid-19-biorepository/ Add to Contact List

To support and accelerate the development and validation of quality in-vitro diagnostics for COVID-19, the Washington COVID-19 Biorepository is a collection of COVID-19 clinical specimens hosted by PATH in Seattle, Washington, USA. The repository includes clinical samples of nasal eluate, tongue swabs, serum, and plasma. These de-identified clinical samples were collected during active community transmission as part of routine clinical care. Individuals were confirmed with a clinical diagnosis of COVID-19 after being tested with an RNA COVID-19 diagnostic test. Limited serum and plasma samples are also available from a longitudinal cohort. Contrived spiked samples from clinical specimens and/or inactivated virus support early R&D efforts for nucleic acid and antigen detection assays. This biorepository is designed to be globally accessible to diagnostic developers with priority given to groups demonstrating commercial efforts to support low-and middle-income countries in their effort to respond and control COVID-19. Due to the unique and limited nature of some of these samples, requests will be reviewed by a governance committee to ensure scientific, ethical, and mission alignment to prioritize use for tests intended for global markets that can be manufactured at scale.

Contact Information

Last Updated: 06/28/2021

Annual Statistics